Drugmakers Expedite Shipments to the U.S. Ahead of Tariffs
A new poll has industry leaders warning that tariffs will disrupt U.S. healthcare costs and supply chain stability
Read More
Talkspace Introduces AI-Powered Personalized Podcasts
Talkspace introduced Talkcast on Monday, an AI-powered feature that allows therapists to generate personalized podcast episodes for clients. The post Talkspace Introduces AI-Powered Personalized Podcasts appeared first on MedCity News.
Health Net’s Innovative Care Transitions Program Moves the Needle
A pioneering program is improving patient outcomes in and outside hospitals
How Is Robotic Process Automation Evolving in Healthcare?
Baker Tilly’s David Hickey says that with health systems under financial pressure, the use of ‘digital workers’ is going to make more sense moving forward
Telemedicine Advocacy Group Buys Digital Therapeutics Alliance
Goal is to create a ‘unified voice to shape healthcare policies, ensuring that telehealth and digital therapeutics remain integral components of the U.S. healthcare system’
Vertex Cell Therapy Misses in the Clinic, But It Has Other Shots on the Type 1 Diabetes Goal
Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early look at Phase 1/2 data fell short of efficacy goals. This program came from a $950 million acquisition in 2019 that marked Vertex’s entry into type 1 diabetes. The post Vertex Cell Therapy Misses in…
Top Vaccine Official Resigns, Citing Misinformation by RFK Jr.
RFK Jr.’s anti-vaccine beliefs lead to changes within the HHS
Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes
That is the title of a new paper with Shanshan Wang, Jaehong Kim, and Slaven Sikirica that has the subtitle “Budget impact analysis from the US payer perspective.” That abstract is below: BACKGROUND:Heart failure (HF) is a leading cause of mortality in the United States, often complicated by comorbidities like diabetes mellitus. These patients face…
Medicare Program Integrity and Efforts to Root Out Improper Payments, Fraud, Waste and Abuse
This brief explains fraud, waste, abuse, and improper payments in Medicare and describes actions to ensure Medicare program integrity.
How Real-World Data Can Support Label Extension And Safer Use Of Novel Therapies
Engaging in data sharing, observational cohort research, and deeper analysis of available data to yield further insights can drive improved results for patients, making label and cohort extension faster and more robust. The post How Real-World Data Can Support Label Extension And Safer Use Of Novel Therapies appeared first on MedCity News.